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The paper illustrates obligations emerging under articles 9 and 89 of the EU Reg. 2016/679 
(General Data Protection Regulation, hereinafter “GDPR”) within the health-related data pro- 
cessing for research purposes. Furthermore, through a comparative analysis of the national 
implementations of the GDPR on the topic, the paper highlights few practical issues that 
the researcher might deal with while accomplishing the GDPR obligations and the other 
ethical requirements. The result of the analyses allows to build up a model to achieve an 
acceptable standard of accountability in health-related data research. The legal remarks are 
framed within the myth of Ulysses. 
© 2020 Published by Elsevier Ltd. 
This is an open access article under the CC BY-NC-ND license. 
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 1. The myth of Ulysses in the literature 
Ulysses, according to the Homer’s epic poem the Odyssey, was
king of Ithaca, son of Laertes and Anticleia, and father of
Telemachus. Ulysses was described as a man of outstanding
intelligence, wisdom, and endurance. Ulysses is cunning as he
is able to overcome insurmountable obstacles to shape reality.
For this reason, in literature the myth of Ulysses and his travel
became the symbol of the scientific progress.1 
This is particularly true in the Divina Commedia , where in
Canto XXVI of the Inferno Dante meets Ulysses. Even if the
Ulysses’ insatiable desire of secular knowledge is considered
as an opposite value respect to the ethical spiritual ascension,
and this caused the impossibility to pursuing his journey withE-mail address: denise.amram@santannapisa.it 
1 A. Fernandez Cano et al. A narrative review o f Greeek myths as 
interpretative metaphors in educational research and evaluation . Edu- 
cational Research Review. 7(3): 238–248. 
https://doi.org/10.1016/j.clsr.2020.105413 
0267-3649/© 2020 Published by Elsevier Ltd. This is an open access arti
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) Dante, the latter admired his skills and competence, courage
and smartness. 
In the nineteenth century, Ulysses became the intellec-
tual hero, who is far away from the current society, looking
for a safe harbor but always in trouble.2 In twentieth century,
Ulysses is the modern hero bringing the anxieties and suffer-
ings to find the true sense of things.3 Nowadays, the Ulysses
4.0 has been interpreted as a human person in his complexity
of skills and feelings.4 
The fils rouge in the several interpretations of the myth is
how Ulysses faces new challenges during his journey, combin-
ing his technical and organizational skills in order to deal with
(and sometimes overcome) the vulnerabilities and limits of2 U. Foscolo, A Zacinto, 1803. 
3 J. Joyce, Ulysses , Dublin, 1922; G. Pascoli, L’ultimo viaggio , in Poemi 
conviviali , 1904; G. Ungaretti, Allegria di naufragi , 1917. 
4 A. Baricco, Omero, Iliade , Feltrinelli, Milano, 2004; M. Kundera, 
L’ignorance , Paris, 2000. 
cle under the CC BY-NC-ND license. 
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tuman beings. This model is particularly relevant today that 
cientific efforts are addressed to facing COVID-19 pandemia 
hrough new technological solutions aimed at both support- 
ng the early-detection and treatment of the disease as well as 
t managing its social and economics consequences in light of 
 needed balance between fundalmental rights. 
Without pretending to contributing to literature, the idea 
f Ulysses as a researcher, who develops technical skills and 
thical competence to properly achieve his scientific goals, ap- 
ears suitable in order to build up a model of ethical-legal 
ompliance within research and development activities in 
ight of the GDPR principle of accountability. 
In the following paragraphs, we will discuss the ethical- 
egal obligations that the researchers have to deal with while 
rocessing personal data, and in particular, health data, dur- 
ng their journey (i.e. the life cycle of the research), highlight- 
ng through a comparative analysis the critical profiles emerg- 
ng from the current legal framework. 
. GDPR and research: new obligations or new 
pportunities? 
fter the GDPR entered into application, a strong debate arose 
n light of the impact that new regulation had on research. The 
alance between the protection of fundamental rights and the 
ree circulation of data makes the researchers responsible of 
 series of obligations for the whole duration of the research 
ifecycle. 
This could be seen as an obstacle, at least in terms of time 
nd resource allocation. The need to adapt current practices to 
he new paradigm of privacy by design and privacy by default 
pproach with respect to the whole research architecture in- 
ludes the necessity to deal with the adoption of proper tech- 
ical and organizational measures. However, they cannot be 
tandardized for every project, as they should be appropriate 
o the specific activity and they can be replaced during the de- 
eloping of the research, considering the possible introduction 
f new risks or new technologies to mitigate it. 
According to the principle of accountability, in fact, the re- 
earcher has the burden to prove the implementation of the 
entioned measures not only because the project proposal 
as to satisfy a given check list of conditions, but as the re- 
earch methodology itself has to be ethical-legal compliant by 
esign.5 
Therefore, the first skill of our Ulysses 4.0. is the open- 
indness to consider the ethical-legal compliance as a neces- 
ary step despite of the given area of research and regardless 
as well as beyond) the existence of a given check-list section 
n the project proposal template.6 5 M. Koscik. “Data protection and codes of conduct in collabora- 
ive research”. Int. Rev. of Law, Computers & Technology , Volume 32, 
018 – Issue 1, 141 ss.; L. Jasmontaite et al., “Data Protection by 
esign and by Default: Framing Guiding Principles into Legal Obli- 
ations in the GDPR”. European Data Protection Law Review (EDPL), 
018, Vol. 4, Issue 2, pp. 168–189. 
6 EDPB, Opinion 3/2018 concerning the Question and Answers on the 
nterplay between the Clinical Trials Regulation (CTR) and the General 
ata Protection Regulation (GDPR) (Art. 70.1.b)), 23.1.2019. 
b
f
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2
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tIn the daily routine, these profiles might constitute a new 
ombination of procedures, contacts, administrative activities 
hich take time and should be supported by the research in- 
titutions. 
The great challenge that the GDPR launched is to create 
he opportunity of sharing ideas, models, and options in a 
ontinuous interdisciplinary dialogue aimed at addressing re- 
earch and innovation towards the EU values and fundamen- 
al rights. To protect dignity and fundamental rights is the 
ompass to improve society and enhance its values: science 
erves human beings, not viceversa , despite the technological 
rogress goes faster than legal positivism and it has already 
ut (personal as well as non-personal) data analysis as the first 
tep of the research. 
This is true in the case of research dealing with health data,
ince the information connected to such a processing make 
he data subjects particularly vulnerable. 
The GDPR has standardized the legislation at the European 
evel, but at the same time it allowed Member States to na- 
ionally specify conditions and requirement in the context 
f data processing for scientific and statistical research pur- 
oses. This might create an obstacle while the activities (and 
herefore the processing of personal data related to them) are 
requently conducted by partnerships belonging to several na- 
ionalities. 
From this viewpoint, it is certainly useful to compare dif- 
erent national interpretations in order to compare the im- 
lemented/proposed national models to find out possible best 
ractices which may address the discussion towards a specific 
ode of conduct. 
For this reason, considering the new ethical-legal issues 
merging from the scientific-technological progress that in- 
olves a daily use of health-related data, our comparative 
nalysis will firstly discuss the legal bases for health data pro- 
essing for research purposes in order to identify the critical 
rofiles as well possible practical solutions that might help 
lysses 4.0. to develop the “accountability” virtue. 
.1. Health data processing for research: the GDPR 
ramework and the legal basis 
ealth-related data are those information which are relevant 
or health conditions, i.e. reproductive outcomes, causes of 
eath, and also the quality of life.7 For this reason, they are 
ncluded in the list of personal data considered as sensitive 
nder article 9 GDPR. This article regulates the legal bases to 
rocess data belonging to the so-called “particular categories”.
First of all, to allocate the data subject “responsibility” of 
he whole data processing, national implementations prefer 
o asking for the consent to data processing, even if other legal 
ases might be applied. 
This tension reflects a sort of confusion between the in- 
ormed consent for volunteers who participate to a research 
xperiment and the information about personal data process- 
ng as well. 7 McGraw-Hill, Concise Dictionary of Modern Medicine. McGraw-Hill. 
002. For further remarks, G. Comandé-G.Malgieri. “Sensitive-by- 
istance Quasi-health Data in the Algorithmic Era”. 2017, Informa- 
ion and communication technology law 26, 229 ff. 
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9 During the publication of this paper, the scientific commu- 
nity focused on the ethical and legal issues emerging from the 
COVID-19 emergency management. In particular, the necessity 
to balance individual and collective health protection and per- 
sonal data protection stimulated an interesting and inditersci- 
plinary debate, that we cannot avoid. See, COMANDÉ, Giovanni; 
AMRAM, Denise; MALGIERI, Gianclaudio. The democracy of emer- 
gency at the time of the coronavirus: the virtues of privacy. Opinio 
Juris in Comparatione, [S.l.], mar. 2020. ISSN 2281-5147. Avail- 
able at: http://www.opiniojurisincomparatione.org/opinio/article/ 
view/144/152 . Date accessed: 19 Apr. 2020. 
10 The involvement of human being in a research, both for
clinical and not clinical trials, in fact, requires to ask for their
consent, therefore the overlap of the procedure is quite com-
mon. 
However, instead of asking for consent for data process-
ing under article 6 sub a) or 9, para 2, sub a) GDPR, data might
be processed in the public interest of the controller under
article 6 sub e) and art. 9, para 2, sub i) or j) GDPR) or pur-
suing a legitimate interest (article 6 sub f) and art. 9, para
2, sub j) GDPR), in light of article 89 GDPR, which regulates
the data processing for archiving purposes in the public in-
terest, scientific or historical research purposes or statistical
purposes. 
According to the GDPR system, in fact, the data subject’s
consent could be seen as a residual legal basis, considering
that transparency and awareness are in any case achieved by
the information under article 13 ff. GDPR, which are due re-
gardless the legal basis of the data processing. 
Moreover, to collect consent does not mean only to sign a
form, but it means to be responsible that the obtained con-
sent is informed, relating to a specific purpose, unambiguous,
freely given, as stated by article 4 GDPR and explained in the
recitals 40 ff. The right to revoke it should be always guaran-
teed. This might constitute an issue, if we consider that the
favor for data processing for research purposes, and the pre-
sumption of conformity of re-using for research purposes un-
der article 5 sub b) and e) GDPR are strictly connected to the ar-
ticle 89 GDPR paradigm, which recalls the necessity to imple-
ment appropriate safeguards that the researcher has to adopt
to minimize any risks. 
Some critical profiles emerge from article 9, para 4, GDPR
which allows Member States to decide whether or not main-
taining the legal bases provided by the EU Regulation or in-
troducing further conditions, including limitations, with re-
gard to the processing of particularly sensitive data, like
the genetic data, the biometric ones, or those concerning
health. 
This reduces the room of harmonization of the legal basis
to process health-related data, also for research purposes. In
fact, article 89 GDPR offers the opportunity to Member States
to provide derogation to data subjects’ rights while process-
ing personal data under the proper safeguards (such as the
pseudonymization and anonymization). At this regard, the
Spanish Ley Orgánica de Protección de Datos Personales 8 states
that limits to the exercise of data subjects’ rights are valid only
if addressed to the researchers that process anonymized or
pseudonymized data. 
In light of this provision, some systems have introduced
new rules or updated the previous legal framework, identi-
fying specific conditions and requirements applicable also in
case of health-related data processing for research purposes.
The topic has been highlighted in the last weeks while na-8 Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos 
Personales y garantìa de los derechos digitales, https://boe.es/boe/ 
dias/2018/12/06/pdfs/BOE- A- 2018- 16673.pdf. A. Mantelero – D. Po- 
letti (Eds.), Regolare la tecnologia: il Reg. UE 2016/679 e la protezione 
dei dati personali. Un dialogo fra Italia e Spagna , Pisa University Press, 
Pisa, 2019. tional legislators have been introducted specific provisions to
deal with the COVID-19 emergency.9 
For example, the Irish Data Protection Act 2018,10 which re-
placed the previous Data Protection Acts in light of the GDPR,
states under the article 36 that the suitable and specific mea-
sures for processing sensitive data also for research purposes should
be regulated in a further specific act: the Health Research Regula-
tion 2018 11 (hereinafter “HRR”). 
According to the HRR, the data controller who is processing
or further processing personal data for the purposes of health
research shall ensure that the collection of an explicit consent
from the data subject, before starting the health research. The
consent could be obtained “either in relation to a particular area
or more generally in that area or a related area of health research,
or part thereof ”. The favor for the application of article 9, para
2, sub j) is anyway recovered when there is a public interest
in the research as declared by a specific committee appointed
by the Health Ministry. In that case, the Data Protection Im-
pact Assessment under article 35 GDPR should be performed
together with the positive approval from the ethics commit-
tee. 
Likewise, the Italian ethics rules adopted by the Italian
Data Protection Authority to process personal data for scien-
tific research and statistical purposes, namely Regole deonto-
logiche per trattamenti a fini statistici o di ricerca scientifica pub-
blicate ai sensi dell’art. 20, comma 4, del d.lgs. 10 agosto 2018, n.
101 ,12 refer to the consent as a legal basis to process sensi-
tive data under article 9 GDPR. For medical, biomedical, epi-
demiological research, article 8 of the above-mentioned ethics
rules states that data subjects/patients should be able to dis-
tinguish through proper information data flows for healthcare
purposes and data flows for research purposes, but consent
seems to be maintained as the principal legal basis to pro-
cess data. This might be misled if it is not compared with ar-
ticle 110 of the Privacy Code Legislative Decree n. 196/2003, as
amended by the Legislative Decree 101/2018, a higher rank-
ing rule.13 It states, in fact, that consent it is not necessary
if the legal basis is article 9, para 2, sub j) and a data protec-
tion impact assessment has been performed and published.
The provision is quite cryptic as it is not evident which areData Protection Act 2018, n. 7/2018, in http://www. 
irishstatutebook.ie/eli/2018/act/7/enacted/en/pdf. 
11 Data Protection Act 2018 (Section 36(2)), Health Research Regu- 
lation 2018, S.I. N. 314 of 2018, http://www.irishstatutebook.ie/eli/ 
2018/si/314/made/en/pdf. 
12 G. Taddei Elmi, “Art. 110”, in R. Sciaudone – E. Caravà (Eds.), Il 
codice della privacy , Pacini Ed., Pisa, 2019, 446 e ss. 
13 G. Comandé. “Ricer ca in sanità e data protection un puzzle... 
risolvibile”, in Rivista italiana di medicina legale e del diritto nel campo 
sanitario, 1, 2019, 188. 
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hhe cases where article 9, para 2, sub j) is not applicable and it 
oes not explain how the data protection impact assessment 
hould be published to fulfill the requirements. Furthermore,
ccording to the mentioned article, the consent is not required 
hether there is a positive approval from an ethical commit- 
ee and a prior consultation before the data protection author- 
ty has been performed. Also this exception may create some 
ractical issues if we consider that data protection is an eth- 
cal profile that an ethical committee should face in its opin- 
on. The relationship between data protection compliance and 
thical compliance is, again, recalled within the article 8 of the 
thics rules. Its para 4, indeed, states that the informed con- 
ent under the Oviedo Convention and Helsinki Declaration 
hall include information about incidental findings, while in 
he previous paragraphs the topic was the legal basis for data 
rocessing. This combination of provisions on privacy infor- 
ation and informed consent misleads the GDPR paradigm 
hich promotes data circulation, under the principles of data 
rotection by design and by default, instead of requiring the 
ata subject’s consent. 
Another group of legal systems, instead, did not introduce 
he consent as a further condition under article 9, para 4,
DPR, but established additional measures to allow health 
ata (as well as genetic or biometric ones) processing. This is 
he case of the Belgian Loi relative à la protection des personnes 
hysiques à l’égard des traitements de données à caractère person- 
el ,14 which for example provides specific confidential obliga- 
ions for those who processes, at any title, sensitive data. Re- 
earch purposes conditions are included in article 186 ff. of the 
entioned Act. Further organizational measures, like the ne- 
essity to appoint a data protection officer (DPO) even if not re- 
uired for the data controller according to the article 37 GDPR,
re stated in case the data protection impact assessment con- 
iders a high risk. The data processing record under article 30 
DPR must include (i) the reasons that justifies the public in- 
erest in pursuing the research or in further processing data 
nd how the possible lack of information might be justified by 
he anonymization (the pseudonymization or the reasons to 
void it) or the risk to compromise the research, and (ii) the 
greement between who firstly collected data and the further 
rocessing actors. 
The Belgian approach addresses the debate on the role of 
he legal basis compared to a series of other ethical-legal re- 
uirements while processing sensitive data for research pur- 
oses. Indeed, pursuing the data protection by design and 
y default in a project means to build up a complex system 
f checks and balance, through organizational and technical 
easures discussed between the several expertise involved in 
he research. Their implementation ensures that the research 
utput will be aligned with the EU values and fundamental 
ights. 14 Loi relative à la protection des personnes physiques à
’égard des traitements de données à caractère personnel , 
0.7.2018, https://www.ipnews.be/wp-content/uploads/2018/ 
9/20180730- Loi- belge- adaptant- réglementation- belge- au- RGPD. 
df. 
G
o
d
s
s
d
t
t. Data protection and the other ethical issues 
ccording to the above-discussed system, the data controller 
i.e. the university/research institute in person of the legal rep- 
esentative) shall involve the principal investigator in the data 
anagement activities, authorizing to data processing under 
rticle 29 GDPR, in order to proactively guarantee the adop- 
ion of those technical and organizational measures aimed at 
afeguarding the rights and freedoms of data subjects in her 
roject. 
This first organizational measure that a research institute 
as to apply is to appoint a role in the privacy orgchart to the
rincipal investigator of each research. At the same time, this 
elps to sensitize, trains, makes each Ulysses 4.0 responsible 
f a data protection by-design research, and let the data con- 
roller achieve the compliance with the principles of correct- 
ess, transparency, and minimization under article 24 GDPR. 
However, this might not be sufficient since the principal 
nvestigator might not have an ethical-legal background able 
o identify those proper safeguards that would make her re- 
earch compliant with the current legal framework. 
At this regard, a principal investigator non-GDPR expert 
ay consider a double level of ethical-legal experts’ involve- 
ent. 
The first level concerns the data protection officer ap- 
ointed by the data controller under articles 37 ff., who – in 
ight of the principle of proximity – shall be able to deal with 
esearch issues and be a key-person between the principal in- 
estigator, the data controller, the ethics committee, the IT 
ervices, and the data protection authority. This supposes a 
trong collaboration with the administrative staff that sup- 
orts the research. 
The second level refers to the increasing role played by 
n ethical-legal unit as a partner of the developed project. Its 
ask is to help the principal investigator to design and imple- 
ent the research in compliance with the whole ethical-legal 
ramework during the entire duration of the project. Consid- 
ring the ethical-legal challenges emerging from the current 
egal-ethical framework, to address an impact assessment on 
he basis of the risk for the shared values and fundamental 
ights could enhance the given research not only in terms of 
nnovation, but also for the consequences on the society, econ- 
my etc. 
The involvement both of a DPO and an ethical-legal unit 
ould make the difference in terms of achieving the goal of an 
thical-legal compliant research by design and by default in a 
iven system. 
In fact, it strengthens the interdisciplinary dialogue and 
elps the cross-fertilization between different domains. 
According to the current national implementations of the 
DPR, in fact, many systems, like the above-illustrated Belgian 
ne have introduced check-lists and protocols to properly ad- 
ress the data protection compliance activities. 
For example, in the Spanish system, firstly, an impact as- 
essment must be carried out; secondly, the research must be 
ubjected to quality standards according to the international 
irectives and clinical best practices; thirdly, it is necessary 
o implement tools aimed at avoiding the re-identification of 
he data subjects; finally, the Spanish law requires the ap- 
computer law & security review 37 (2020) 105413 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 The statement recalls Recital 26 GDPR. See P. Quinn. “The 
Anonymisation of Research Data—A Pyric Victory for Privacy that 
Should Not Be Pushed Too Hard by the EU Data Protection Frame- 
work?”, European Journal of Health Law. 24, 2017, 22 p. 2017. 
16 WP Article 29, Opinion 5/2014 on Anonymisation Techniques , 
adopted on 10 April 2014. See D. Korff – M. Georges, Passen- 
ger Name Records, data mining & data protection: the need 
for strong safeguards, report for the Council of Europe Con- 
sultative Committee on data protection, June 2015, Council 
of Europe document T-PD(2015)11, section I.iii, The dangers in- 
herent in data mining and profiling , available at: https://www. 
coe.int/t/dghl/standardsetting/dataprotection/TPD _ documents/ 
T - PD(2015)11 _ PNR%20draft%20report%20Douwe%20Korff%20&% 
20Marie%20Georges _ 15%2006%202015.pdf. See the Irish Data 
Protection Commission, Guidance Note: Guidance on Anonymisation 
and Pseudonymisation , June 2019. G. Comandé – G. Schneider, 
“Regulatory Challenges of Data Mining Practices: The Case of the 
Never-ending Lifecycles of ‘Health Data’”, 25 Eur. J. Health Law , 
2018, 284 ss. pointment of a legal representative in the European Union
under the article 74 EU Reg. 536/2014 and 21 GDPR in case of
extra-EU partnerships. The provision 17 sub g), indeed, states
that in case the ethical committee cannot express an ap-
proval, the principal investigator may ask the data protec-
tion officer’s one. However, it specifies that ethical commit-
tees should add specific competence on data protection by
one year. 
From this perspective, as far as health data are concerned,
data protection compliance walks together with the ethical
one. Therefore, the ethical committees should empower their
competence on data protection and the data protection officer
shall be able to address the researcher to an ethical-legal unit
or legal-ethical advisor. 
The proactive risk-based approach which has been im-
plemented by the GDPR for data processing could be po-
tentially applicable to all the ethical issues emerging in the
research. 
To this end, the already mentioned Irish HRR takes the op-
portunity to deal with the ethical profiles related to research
(e.g. informed consent, voluntary research, cost-benefits as-
sessment with respect to the clinical trial, conflict of interests
etc.) answering the need to develop a coherent paradigm to
properly process health data for research purposes. The HRR
firstly provides a definition for “Health Research”, listing 5 sci-
entific areas for the purpose of human health, including: “(i)
research with the goal of understanding normal and abnormal func-
tioning, at molecular, cellular, organ system and whole body levels;
(ii) research that is specifically concerned with innovative strategies,
devices, products or services for the diagnosis, treatment or preven-
tion of human disease or injury; (iii) research with the goal of improv-
ing the diagnosis and treatment (including the rehabilitation and pal-
liation) of human disease and injury and of improving the health and
quality of life of individuals; (iv) research with the goal of improving
the efficiency and effectiveness of health professionals and the health
care system; (v) research with the goal of improving the health of the
population as a whole or any part of the population through a better
under- standing of the ways in which social, cultural, environmental,
occupational and economic factors determine health status ”. 
Then the HRR recalls the ethical issues to be assessed by
the ethical committees for approval: data protection is one of
them, but it finds a specific development in article 3 and ff. Ar-
ticle 3 states that personal data can be processed for research
purposes as long as it is necessary to achieve the research pur-
poses and it does not cause any damage or distress to the data
subject and if the organizational measures stated sub b) are in
place. 
The check-list that follows is a sort of data protection plan,
which includes the ethical approval by an ethical commit-
tee, the identification of the privacy governance structure (in-
cluding joint controllers, data processors, and recipients), the
training programme for those who are involved in the re-
search, the data protection impact assessment for higher pro-
cessing risks. 
The Italian ethics rules issued by the Data Protection Au-
thority, instead, identify the field of application under a sub-
jective requirement: “to all the data processing carried out for sta-
tistical and scientific purposes – in accordance with the methodolog-
ical standards of the relevant disciplinary sector – which are held
by universities, other research institutions and research institutesand scientific societies, as well as researchers operating within the
scope of said universities, institutions, research institutes and mem-
bers of these scientific societies ”. To this end, marketing purposes
hidden under “research or statistical” purposes are excluded
since private companies are included only if in their company
bylaws research activities are mentioned. 
4. Pseudonymization, anonymization, and 
data re-using for research purposes 
According to the article 89 GDPR data processing for archiving
purposes in the public interest, scientific or historical research
purposes or statistical purposes, shall be subject to appro-
priate safeguards. The same article refers to pseudonymiza-
tion as the first measure aimed at achieving the minimization
purposes. For further processing, it states that a further level
“which does not permit or no longer permits the identification
of data subjects” should be gained.15 Technically, it does not
exist a unique criterion of anonymization. Data can be con-
sidered anonymized having regard to any methods reasonably
likely to be used by the data controller (or any third party) to
reverse the process and allow the re-linking of the data sub-
ject. The assessment is based on the risk of re-identification
through a rational effort.16 
Therefore, the pseudonymization standard could be always
obtained through technical separation of information, consid-
ering several levels (e.g. scrambling, encryption, masking, to-
kenization, data blurring, etc.) while the anonymization could
be achieved by the combination of technical and organiza-
tional measures as well, considering the features of the data
controller. 
Some national implementations of the article 89 GDPR fo-
cused on this profile. 
The Belgian law establishes, in case of health data pro-
cessed for research purposes, that pseudonymization could
not be performed by the data controller, but by an indepen-
dent body, who is subject to specific confidentiality obliga-
tions (i.e. professional secrecy). At this regard, the Spanish
law requires a “technical separation” between who performs
the two activities and an explicit obligation for the ones who
pseudonymized to avoid re-identification. 
These provisions arise two issues. 
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nFirstly, when the data controller is a research hospital,
ealthcare purposes and scientific ones might be performed 
t the same time by the same team. In this context, despite 
f the application of pseudonymization techniques, clinicians 
ight be always able to recognize and refer to their patients,
ven if committed to professional secrecy. 
Secondly, to always identify a partner or team for 
seudonymization could constitute an expense for the re- 
earch: perhaps it could be sufficient to appoint such a task 
o IT services of the data controller and establishing granular 
ccessibility to the token (e.g. only the principal investigator,
ut not the research team). 
The article 110 bis of the Italian Privacy Code refers to the re- 
sing of data by third parties.17 First condition is that data sub- 
ects must be informed. Otherwise a prior authorization from 
he data protection authority is needed. This approach is not 
pplicable whereas personal data are collected for healthcare 
urposes and used for research ones by the same research 
linics, considering the functional link between the two pur- 
oses. The provision seems to refer to patients’ personal data 
efore being pseudonymized or anonymized for research pur- 
oses, as stated under article 89 GDPR. 
Another profile of the GDPR compliance consists of the 
ystem security: data flows are usually in a digital format,
herefore proper measures shall be implemented to guaran- 
ee the availability, integrity and confidentiality of data. As far 
s the security of data is concerned, the Irish act, for exam- 
le, refers to the criterion of the “effectiveness” of the adopted 
easures. 
So far, the interdisciplinary dialogue touches the fields of 
he data management, including IP rights. 
If we consider that open access is becoming the new stan- 
ard to manage research data, the role of the data protection 
fficer/expert/advisor becomes essential to establish which 
ata can be shared or not. 
Therefore, skills required to Ulysses 4.0 and his crew be- 
ome everyday more specialized ones. In the context of the 
OVID-19 pandemia, for example, during the so called lock- 
own, governments opted for establishing interdisciplinary 
ask forces aimed at identifying effective, ethical-legal, suis- 
anable solutions to plan a safe re-starting of the activities.18 
his strategy appears in line with the Ulysses 4.0 model. 
. Towards the “Accountable Ulysses”
tandard 
s shown in the previous paragraphs, the “accountable 
lysses” is a standard which might be achieved only estab- 17 S. Melchionna, “Art. 110 bis ”, in R. Sciaudone – E. Caravà (Eds.), Il 
odice della privacy, cit. 461 ss. 
18 See the debate on the so called contact tracing technolo- 
ies. E.g. ICO, Apple and Google joint initiative on COVID- 
9 contact tracing technology, 17 April 2020 Reference: 2020/0, 
vailable at https://ico.org.uk/media/about- the- ico/documents/ 
617653/apple- google- api- opinion- final- april- 2020.pdf; EU Com- 
ission, E-health Network Mobile applications to support contact 
racing in the EU’s fight against COVID-19, https://ec.europa.eu/ 
ealth/sites/health/files/ehealth/docs/covid-19 _ apps _ en.pdf. 
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aishing an interdisciplinary dialogue between the researcher 
n different fields. Starting from this principle, some common 
eatures can be identified to reach an acceptable level of com- 
liance. 
i) Whereas health data are processed, to involve ethical- 
legal experts, who could play either an institutional role 
(as the data protection officer) or being a partner of the 
research, since the beginning of the project proposal 
is an added value to design an ethical-legal compliant 
ecosystem. Ulysses cannot avoid from including an in- 
terdisciplinary support in her crew. 
ii) Research purposes are functional to empower human 
dignity and values. Considering the strong impact on 
individuals as well as on groups, as the research could 
identify new vulnerabilities, or classify individuals (as 
more exposed to a given risk), Ulysses processing health 
data shall adopt suitable and effective technical and 
organizational measures to ensuring the ethical-legal 
compliance, in order to avoid possible misuse or dual 
use. 
iii) The IT infrastructure and data management strategy 
should be designed in order to guarantee the availabil- 
ity, confidentiality, integrity of data. 
iv) If Ulysses is also a physician, the combination of data 
processed for healthcare and scientific research should 
be clearly distinguished and therefore following possi- 
ble different data protection plans: risks, technical pro- 
tocols, access, time retention, level of pseudonymiza- 
tion might be different. 
v) Data flows should be regulated between partners as well 
as within the given research teams. 
vi) Data flows should be recorded and described in the in- 
formation given to data subjects. 
vii) Data protection is one of the several ethical issues 
that might arise from a research. The coordination 
between different legal constrains, protocols, and re- 
quirements should be analyzed in terms of risk assess- 
ment and monitored during the whole life-cycle of the 
research. 
The GDPR introduced a new proactive approach to data- 
ntensive research. Its handling supposes the cross fertiliza- 
ion between different domains, where the legal one plays 
he role to establish boundaries between lawful and unlawful,
ontributing to identifying possible tensions under the ethical 
ramework. 
In order to sensitize Ulysses to this new approach, which 
ecessarily includes the allocation of time and resources, a 
oherent ethical-legal support to the core-research should 
e promoted by the research institutes. In this perspec- 
ive, Ulysses does not represent only the principal investi- 
ator of a given research, but the university/research insti- 
ute per se , which as the data controller, should firstly train 
he research staff and the administrative staff to ethical-legal 
ompliance, inform on duties and responsibilities, organiz- 
ng and introducing specific support. In other terms, be ac- 
ountable both within the technical and the organizational 
ctivities. 
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 Therefore, Ulysses 4.0 is the one who embraces a new way
of working, as it has been stressed during these last weeks
within the analysis of the solution to combat COVID-19,19 
open to assess together with the technical specifications the
ethical-legal consequences not only in order to mitigate the19 EU Commission, Joint European Roadmap towards lifting 
COVID-19 containment measures, https://ec.europa.eu/info/sites/ 
info/files/communication _ - _ a _ european _ roadmap _ to _ lifting _ 
coronavirus _ containment _ measures _ 0.pdf. 
 risk to compromise fundamental rights, but to empower hu-
man dignity as main core of her research. 
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